A detailed history of Brogan Financial, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Brogan Financial, Inc. holds 3,020 shares of ABT stock, worth $316,043. This represents 0.23% of its overall portfolio holdings.

Number of Shares
3,020
Previous 3,948 23.51%
Holding current value
$316,043
Previous $435 Million 21.01%
% of portfolio
0.23%
Previous 0.32%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$109.52 - $120.96 $101,634 - $112,250
-928 Reduced 23.51%
3,020 $343 Million
Q4 2023

Feb 09, 2024

BUY
$90.19 - $110.4 $1,803 - $2,208
20 Added 0.51%
3,948 $435 Million
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $382 - $458
4 Added 0.1%
3,928 $380 Million
Q2 2023

Aug 10, 2023

BUY
$100.78 - $112.29 $503 - $561
5 Added 0.13%
3,924 $428 Million
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $387 - $456
4 Added 0.1%
3,919 $397 Million
Q4 2022

Feb 14, 2023

BUY
$95.06 - $111.52 $372,159 - $436,600
3,915 New
3,915 $430 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $183B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Brogan Financial, Inc. Portfolio

Follow Brogan Financial, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brogan Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Brogan Financial, Inc. with notifications on news.